Arrowgrass Capital Partners (US)’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-529,685	Closed	-$91.5M	–	614
2015 Q1	$91.5M	Buy	+529,685	New	+$77.8M	1.41%	10
2014 Q4	–	Sell	-129,003	Closed	-$20.2M	–	515
2014 Q3	$20.2M	Buy	+129,003	New	+$18.7M	0.49%	36

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s SLXP Position: Q2 2015 in Review

Arrowgrass Capital Partners (US) sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 529,685 shares — an estimated $91.5M sold.

Arrowgrass Capital Partners (US) first reported a position in SLXP in Q3 2014 and held it in 2 quarters. The position peaked at $91.5M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Arrowgrass Capital Partners (US) reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Arrowgrass Capital Partners (US) sold 529,685 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $91.5M.
Arrowgrass Capital Partners (US) first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 2 quarters.
Arrowgrass Capital Partners (US)'s SALIX PHARMACEUTICALS LTD DEL position peaked at $91.5M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q2 2015, filed 14 Aug 2015.